FDA clears new AI algorithm for triaging pneumothorax

Matt O'Connor | | Health Imaging | Policy & Regulations

The U.S. Food and Drug Administration has cleared a new artificial intelligence system that detects pneumothorax on x-rays and quickly alerts radiologists. 

London-based imaging tech company Behold.ai received the green-light for its red dot “instant triage” platform, the company announced late last week. It also said users will be charged on a per-exam basis, with plans to release the platform in the U.S. later this year.

Additionally, Behold.ai said highly experience radiologists helped train the technology and three board-certified radiologists validated the approach against more than 800 cases in the U.K and U.S.

“We are delighted to have received clearance for our algorithm in the U.S.,” Simon Rasalingham, chief executive of Behold.ai, said in the announcement. “FDA clearance is not just about safety but also about efficacy. We believe our technology can make a big difference to patient safety, the delivery of care and cost savings to the system.”

""
Matt O'Connor

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Related Content

FDA clears AI-assisted CCTA software that assesses plaques for signs of heart disease
University of Missouri Health Care's 7T scanner joins exclusive ACR accreditation club
Radiologist arrested for secretly recording female patient's breasts during imaging
Why cardiac CT adoption remains low among primary care providers
Injuries trigger recall related to tables used during image-guided procedures
New FDA-cleared algorithm could improve fetal anomaly detection on ultrasound

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.